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Background. Unexplained intrauterine death (IUD) remains the most common cause of perinatal death in babies of <1 000 g in South 
Africa (SA). Information from examination of the placenta subsequent to an adverse perinatal outcome is often underutilised and 
placental histology can contribute to determining the cause of perinatal death and other adverse outcomes in many instances.
Objectives. To correlate placental histopathology with the clinical indication for submission and to demonstrate the value of placental 
histopathology in understanding adverse perinatal outcomes.
Methods. We reviewed 2 years’ singleton placental histology reports at a tertiary academic hospital in the Western Cape, SA. All samples 
were from placentas of >24 weeks’ gestation. 
Results. The total sample (N=822) comprised 60.9% live-birth placentas and 39.1% IUD placentas. In the IUD group, the cause of death 
was clinically unexplained in 55.9% of cases. Histopathology identified in this group included chorioamnionitis (CA) (34.5%), maternal 
vascular malperfusion (32.1%), abruptio placentae (31.5%), delayed villous maturation (17.8%) and toxoplasmosis, other agents, rubella, 
cytomegalovirus and herpes simplex (TORCH) infections (6.1%), most commonly syphilis. No pathology was found in only 2% of IUD 
cases. Among live births, preterm labour accounted for 41.9% of placental submissions, of which the cause was unknown in 46.2% of cases. 
Clinically indicated and histologically defined CA was poorly correlated.
Conclusion. This study demonstrates the value of placental histopathology in cases of adverse perinatal outcome. 
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Data from the Perinatal Problem Identification Program (PPIP), 
in which close to 75% of all births in institutions were recorded 
between January 2012 and December 2013, show that unexplained 
intrauterine death (IUD) represents the largest category of perinatal 
death in babies of <1 000 g in South Africa (SA).[1] In the majority 
of these cases, the diagnosis is based purely on clinical assessment, 
without autopsy or histology of the placentas. The PPIP report 
recommended that ‘funding and research resources must be directed 
(at) identifying the causes of death in this group’.[1]
Intrapartum asphyxia is reported as the most common cause of 
fresh IUDs[1] and, along with prematurity, also as the most common 
cause of early neonatal death. However, intrapartum asphyxia, 
defined as deprivation of oxygen supply to the fetus during labour, 
is notoriously overdiagnosed. The only reliable predisposing factors 
are sentinel events such as uterine rupture, cord prolapse or abruptio 
placentae.[2]
Several studies, albeit performed in high-income countries, 
have shown that only 8 - 10% of cases of cerebral palsy result from 
intrapartum hypoxia.[2-4] Placentas have up to 50% reserve capacity 
and compromised placentas may function adequately but be unable 
to cope with the stress of normal labour, resulting in hypoxia during 
delivery.[2,5] A number of earlier studies have shown that placental 
lesions involving the placental vasculature (such as fetal thrombotic 
vasculopathy and meconium-associated vascular necrosis of the 
umbilical cord) or the placental parenchyma (such as diffuse chronic 
villitis or increased perivillous fibrin) may be associated with 
cerebral palsy and neurological injury at term.[5,6] However, without 
histopathological examination of the placenta, such entities will not 
be identified and a diagnosis of intrapartum hypoxia may well be 
proffered.
The information gathered from placental examination after 
an adverse outcome of a pregnancy has been underutilised and 
given low priority in the past by obstetricians, neonatologists and 
general pathologists alike. Placental histology helps to assign and 
subclassify the cause of perinatal death in many cases.[7] As there 
remains a reluctance to consent to perinatal autopsy, placental 
histology is often the only source of information regarding the 
cause of stillbirth or neonatal death.[8] Such information may prove 
invaluable in preventing a subsequent stillbirth or identifying 
preventable community risk factors, which may reduce the number 
of unexplained cases of stillbirth. Placental histology is important in 
identifying maternal vascular malperfusion (MVM), infections and 
umbilical cord complications,[9,10] and in cases of litigation against 
hospitals or obstetricians for adverse pregnancy outcomes, placental 
pathology offers objective insights to inform decisions.
The aim of this study was to review 2 years’ placental histology 
records at a tertiary academic hospital in the Western Cape, SA, with 
a view to correlate findings with clinical diagnoses and so determine 
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whether placental histopathology could assist in understanding 
adverse pregnancy outcome in this population.
Methods
We reviewed all singleton placentas of ≥24 weeks’ gestation 
submitted to the Division of Anatomical Pathology at Tygerberg 
Hospital (TBH) from deliveries at this institution between 1 January 
2011 and 31 December 2012. TBH serves as a secondary and tertiary 
referral hospital to a population of approximately 2 million people. 
According to the hospital’s obstetric records (unpublished), ~ 7 000 
deliveries are recorded here annually.
This was a retrospective, descriptive, laboratory-based study. 
The placental examinations were performed in house and reported 
by experienced pathologists according to a standardised reporting 
template (available upon request). The final histological diagnosis 
was correlated with the clinical diagnosis where given. Approval for 
the study was obtained from the Health Research Ethics Committee 
of Stellenbosch University (ref. no. S15/10/218).
Placentas from multiple pregnancies, of ≤23 weeks’ gestation, 
or those submitted from hospitals or clinics other than TBH were 
excluded from the study.
Maternal data were obtained from the request forms submitted 
with the placenta and information available in the laboratory 
database. Data included maternal age, gravidity, parity, presence 
of so-called TORCH (toxoplasmosis, other agents, rubella, 
cytomegalovirus and herpes simplex) infections, HIV status and 
other available medical and obstetric history.
Gestational age, outcome of pregnancy (live birth, miscarriage, 
fetal distress or IUD) and placental data as detailed in the 
standardised template report and diagnosis were obtained from the 
laboratory reports. Patients’ hospital records were not accessed.
Placental lesions were categorised according to the Amsterdam 
Placental Workshop Group’s consensus definitions of placental 
lesions,[11] as listed in Table 1.
Data analysis 
Data were entered into a spreadsheet and exported to SPSS version 
23.0 (IBM Corp., USA) for statistical analysis. Values are presented 
as means and standard deviations for normally distributed data, 
and otherwise as medians, with categorical variables expressed as 
percentages. Differences between variables were assessed using a 
chi-squared test for categorical variables or a t-test for quantitative 
variables with a normal distribution. Results were considered 
statistically significant if p<0.05. 
Results
A total of 822 placentas were included in the study, with 501 (60.9%) 
and 321 (39.1%) being from live births and IUDs, respectively. 
Mean maternal age was 27 years (range 14 - 45 years) and mean 
gestational age was 32 weeks (range 24 - 44 weeks). The mean 
placental weight across 814 cases (no data available for 8 cases) was 
328 g (range 56 - 1 014 g). 
Maternal HIV status was positive in 229 (27.9%) cases and 
negative in 593 (72.1%) cases.
The indications for histology requests included IUD of unknown 
aetiology (n=162; 19.7%), whereas preterm labour of unknown 
aetiology accounted for 11.8% of requests (n=97). Placentas received 
without a clinical indication or history accounted for 5.4% (n=44) of 
the samples and chorioamnionitis (CA) was clinically suspected in 
12.2% (n=100) of cases (Table 2).
Upon comparing the clinical indication for submission with the 
histopathological diagnosis, abruptio placentae (AP) showed 90% 
specificity and 12% sensitivity, with a positive predictive value of 
50% and a negative predictive value of 76%. In 42 cases, AP and CA 
occurred concurrently (inflammatory placental abruption). 
A summary of clinical indications for IUD is given in Table 3. The 
most common indication was unexplained IUD (n=162; 55.9%), 
followed by maternal hypertensive disorders (n=55; 18.9%).
Table 4 summarises the pathology differences between samples 
from live births and stillbirths. Delayed villous maturation (DVM), 
AP, MVM, fetal vascular malperfusion (FVM) and TORCH 
infections were more prevalent in stillbirth placentas than in 
those from live births, all associated with statistically significant 
p-values. 
Table 1. Definitions of placental pathology according to the 
Amsterdam Placental Workshop Group[11]
Placental lesion Features 
Maternal vascular 
malperfusion of the 
placental bed
Placental hypoplasia (weight below tenth 
percentile and cord diameter <8 mm at term)
Infarction 
Retroplacental haemorrhage 
Distal villous hypoplasia 





Segmental avascular villi 
Villous stromal vascular karyorrhexis 
Intramural fibrin deposition




Monotonous villous population with reduced 




Maternal or fetal inflammatory response
Villitis of unknown 
aetiology
Low- or high-grade villitis; no known aetiology; 




Eosinophilic/T-cell vasculitis, chronic 
intervillositis or chronic deciduitis
Table 2. Clinical indication for submission of placentas 
(N=822)
Clinical indication n (%) 
Abruptio placentae 27 (3.3)
Chorioamnionitis 100 (12.2)
Fetal anomalies 30 (3.7)
Fetal distress 29 (3.5)
Hypoxic ischaemic encephalopathy 28 (3.4)
Maternal hypertensive disorders 144 (17.5)
Unexplained IUD 162 (19.7)
Intrauterine growth restriction 29 (3.5)
Maternal disease 76 (9.2)
Preterm labour of unknown aetiology 97 (11.8)
TORCH infection 41 (5.0)
Other 15 (1.8)
No clinical indication 44 (5.4)
IUD = intrauterine death; TORCH = toxoplasmosis, other agents, rubella, cytomegalovirus and 
herpes simplex.
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Discussion
The most common indication for submission of the placenta from 
live births was preterm labour (n=210; 41.9%); in 97 cases (46.2%) 
the cause of preterm labour was unknown. CA and maternal 
hypertension disorders were suspected as cause in 44 (21.0%) and 
18 cases (8.6%), respectively. CA was the most common histological 
finding in placentas from live births (n=154; 30.7%), as shown in 
Table 4.
Identifying the cause of preterm labour is important not only 
for the management of individual cases but also in context of cost 
implications. Predisposing and precipitating factors include CA, AP 
and recurrent lesions such as villitis of unknown aetiology, FVM, 
MVM and massive perivillous fibrin deposition (MPFD). Managing 
preterm neonates has considerable cost implications for both 
the individual and the health system and may be associated with 
significant morbidity.
Fetal distress was cited as a clinical indication for placental 
examinations of live births. Although the clinician suggested 
a possible cause for this based on the clinical presentation of 
the mother or fetus/neonate in some cases, such as maternal 
hypertension (n=144), the cause of the fetal distress was unknown 
in 29 cases (3.5%). The most common histological findings in these 
cases included MVM (n=10), AP (n=5) and CA (n=4). 
In most of the IUD cases submitted for placental examinations, 
the cause of stillbirth was unknown (n=162; 55.9%). Insight into 
the reason for IUD is important to both the clinician and the 
parent(s), as understanding what went wrong can help to give 
the parent(s) closure and prevent their apportioning blame to 
either themselves or the attending clinician for a process that 
may have occurred in the antenatal period. Histopathological 
examination of placentas from unexplained IUDs revealed CA in 
34.6% of cases (n=56), followed by MVM and AP at 32.1% and 
31.5%, respectively. Evidence of DVM was found in 17.8% of the 
unexplained IUD cases and TORCH infections accounted for 6.2% 
of the cases (n=10), the majority of which included treponemal 
infection. MPFD and villitis of unknown aetiology accounted 
for 3.1% and 4.9% of cases in this subgroup, respectively. Only 
five cases of unexplained IUD (3.1%) were without pathological 
findings.
The correlation between clinically suspected and histologically 
confirmed CA in line with the poor concordance reported in 
literature: 100 cases were identified clinically, but 265 cases were 
diagnosed histologically, with a specificity of 90% and a sensitivity 
of 34% (the positive predictive value was 61% and the negative 
predictive value was 74%). In the 154 cases of CA identified in live-
birth placentas, 108 had a fetal response as manifested by funisitis/
vasculitis (70.1%), whereas in the 111 cases of CA in IUD placentas, 
only 55 had a fetal response (49.5%).
Table 3. Clinical indications for intrauterine death (N=290*)
Clinical indication n (%) 
Abruptio placentae 4 (1.4)
Chorioamnionitis 14 (4.8)
Fetal anomalies 8 (2.8)
Fetal distress 2 (0.7)
Intrauterine growth restriction 4 (1.4)
Maternal disease 20 (6.9)
Maternal hypertensive disorders 55 (18.9)
TORCH infection 20 (6.9)
Umbilical cord accident 1 (0.3)
Unexplained IUD 162 (55.9)
TORCH = toxoplasmosis, other agents, rubella, cytomegalovirus and herpes simplex;  
IUD = intrauterine death.
*No clinical indication was noted in 31 cases.
Table 4. Comparison of histopathological findings in placentas from intrauterine deaths and live births
Histopathological finding Outcome Live births (N=501), n (%) IUD (N=321), n (%) p-value
Chorioamnionitis
Negative 347 (69.3) 210 (65.4) 0.250
Positive 154 (30.7) 111 (34.6)
Intervillositis*
Negative 489 (97.6) 310 (96.6) 0.686
Positive 8 (1.6) 9 (2.8)
Delayed villous maturation
Negative 460 (91.8) 258 (80.4) 0.000
Positive 41 (8.2) 63 (19.6)
Abruptio placentae/retroplacental haemorrhage
Negative 396 (79.0) 220 (68.5) 0.001
Positive 105 (21.0) 101 (31.5)
Maternal vascular malperfusion
Negative 363 (72.5) 199 (62.0) 0.002
Positive 138 (27.5) 122 (38.0)
Fetal vascular malperfusion
Negative 491 (98.0) 303 (94.4) 0.005
Positive 10 (2.0) 18 (5.6)
TORCH infection
Negative 488 (97.4) 297 (92.5) 0.001
Positive 13 (2.6) 24 (7.5)
Massive perivillous fibrin deposition
Negative 495 (98.8) 316 (98.4) 0.661
Positive 6 (1.2) 5 (1.6)
Villitis of unknown aetiology
Negative 473 (94.4) 306 (95.3) 0.565
Positive 28 (5.6) 15 (4.7)
Umbilical cord accident
Negative 498 (99.4) 317 (98.8) 0.324
Positive 3 (0.6) 4 (1.2)
No abnormalities
Negative 471 (94.0) 314 (97.8) 0.010
Positive 30 (6.0) 7 (2.2)
*Missing data.
IUD = intrauterine death; TORCH = toxoplasmosis, other agents, rubella, cytomegalovirus and herpes simplex.
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DVM (also known as distal villous immaturity) is not a diagnosis 
but rather a reaction pattern. This condition is frequently 
associated with maternal metabolic conditions such as glucose 
intolerance, obesity and atherosclerosis.[12] Histological evidence 
of DVM in a placental sample is a significant finding, because it 
points to an increased risk for adverse outcomes such as stillbirth, 
unexplained fetal growth restriction, fetal macrosomia and 
neurodisability.[11,12] DVM was present in 8.2% of live births and 
19.6% of IUD cases in our study.
AP is a clinicopathological diagnosis, but may be clinically 
silent. Histopathological diagnosis is based on macroscopic and 
histological findings, with the latter including a constellation of 
microscopic features, such as retroplacental haemorrhage, dissecting 
of blood into the decidua, intravillous haemorrhage and intervillous 
congestion or infarction.[10,11]
MVM has a multifactorial aetiology, but is frequently associated 
with hypertensive disorders of pregnancy, intrauterine growth 
restriction and recreational drug use (including tobacco smoking). 
Hypertensive disorders were among the most common clinical 
indications in our study. They are associated with retroplacental 
haemorrhage.[11,13]
Treponema pallidum infection (part of the TORCH infection suite) 
appeared to be a significant cause of morbidity and mortality in our 
study population, similar to results of other studies in comparable 
settings.[7,14]
Villitis of unknown aetiology is an uncommon but important 
histological finding, as it suggests a risk of recurrence in future 
pregnancies, with increased severity. Its diagnosis can be confirmed 
only by histopathology, although it may be suspected clinically 
owing to its association with intrauterine growth restriction, preterm 
labour and IUD. It is thought to be a maternal immune response to 
fetal antigens.[7,11,13]
There was a significant association between FVM and IUD 
(p=0.005). FVM is associated with maternal thrombophilia, 
antiphospholipid antibody syndrome, abnormal cord insertion or 
cord obstruction and oligohydramnios.[13]
MPFD, although rare, is a notable cause of poor perinatal 
outcome. It is usually undiagnosed clinically and identified 
histologically, although the placentas may be macroscopically 
abnormal. It may be associated with maternal thrombophilia and 
antiphospholipid antibody syndrome and carries a significant 
recurrence risk.[13]
Histopathological examination revealed no abnormalities in 
only 30 of the live-birth placentas (6%) and seven of the IUD 
cases (2.2%). This demonstrates the inestimable value of placental 
histopathology in the case of adverse perinatal outcomes, not only 
for the clinician, the patient and their family, but also in the context 
of health economics.
Study limitations
Clinical data deemed important for the analysis of the submitted 
placentas were limited or absent in a number of cases. It is possible 
that some clinical data may have erroneously been deemed 
unimportant by the submitting healthcare worker. 
Conclusion
Histopathological examination of the placenta provides valuable 
information and can reduce the number of cases of unknown 
aetiology in adverse perinatal outcome. If a placenta is submitted 
for histopathological examination, the accompanying clinical data 
on the request form should be as comprehensive as possible and 
should include, at a minimum, age, obstetric history, comorbidities, 
pregnancy outcome and clinical diagnosis. 
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